Please use this identifier to cite or link to this item: http://repo.knmu.edu.ua/handle/123456789/1922
Full metadata record
DC FieldValueLanguage
dc.contributor.authorStepanova, Olena-
dc.contributor.authorKryuchkiov, Y.-
dc.date.accessioned2012-11-28T07:50:32Z-
dc.date.available2012-11-28T07:50:32Z-
dc.date.issued2012-
dc.identifier.citationStepanova O. Characteristic of trimetazidine MR influence on the CDH course in patients with diabetes mellitus type 2 / O. Stepanova, Y. Kryuchkiov // 5th International Scientific Interdisciplinary Conference (ISIC) for medical students and young doctors, Kharkiv, April 25–26, 2012 : Abstract book. – Kharkiv, 2012. – P. 77–78.uk_UK
dc.identifier.urihttps://repo.knmu.edu.ua/handle/123456789/1922-
dc.description.abstractTrimetazidine MR showed high efficiency in the treatment of patients with CDH and diabetes mellitus type 2. The research has shown that adding trimetazidine MR (dosage 70 mg/day) to the basic therapy is advisable for tolerance increase to the physical activity and improvement of the quality of life in patients with CDH and diabetes mellitus type 2.uk_UK
dc.language.isoenuk_UK
dc.publisherKNMUuk_UK
dc.subjectdiabetes mellitus type 2uk_UK
dc.subjecttrimetazidine MRuk_UK
dc.titleCharacteristic of trimetazidine MR influence on the CDH course in patients with diabetes mellitus type 2uk_UK
dc.typeThesisuk_UK
Appears in Collections:Наукові роботи молодих вчених. Кафедра внутрішньої медицини № 1

Files in This Item:
File Description SizeFormat 
stepanova1.pdf294,82 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.